Endoscopy 2001; 33(8): 645-650
DOI: 10.1055/s-2001-16214
Original Article

© Georg Thieme Verlag Stuttgart · New York

Diamond Stents for Palliation of Malignant Bile Duct Obstruction: A Prospective Multicenter Evaluation

A. Ferlitsch 1 , C. Oesterreicher 1 , J. M. Dumonceau 2 , J. Deviere 2 , T. Leban 3 , P. Born 3 , T. Rösch 3 , W. Suter 4 , J. Binek 4 , C. Meyenberger 4 , M. Müllner 5 , B. Schneider 6 , R. Schöfl 1
  • 1 Dept. of Internal Medicine IV, Division of Gastroenterology and Hepatology, University of Vienna, Vienna, Austria
  • 2 Dept. of Gastroenterology and Hepatopancreatology, Erasme University Hospital Brussels, Brussels, Belgium
  • 3 Klinikum Rechts der Isar, Department of Internal Medicine II, Technical University of Munich, Munich, Germany
  • 4 Dept. of Gastroenterology, Kantonshospital St Gallen, St Gallen, Switzerland
  • 5 Dept. of Emergency Medicine, University of Vienna, Vienna, Austria
  • 6 Dept. of Medical Statistics, University of Vienna, Vienna, Austria
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Preview

Background and Study Aims: Various types of self-expandable metal stents have been introduced for biliary drainage in patients with malignant jaundice, showing prolonged patency compared with plastic endoprostheses. However, there has only been prolonged experience with a meaningful number of patients using the Wallstent. We evaluated the Diamond stent, a self-expanding uncoated biliary metal stent, in a prospective uncontrolled multicenter setting.

Patients and Methods: The eligibility criterion was obstructive jaundice due to inoperable malignant disease. Between August 1995 and January 2000, 126 patients, who received a total of 134 Diamond stents in four European centers, were followed prospectively.

Results: Technical and clinical success rates were 96 % and 98 %, respectively. No major procedure-related complications occurred. The 30-day mortality rate was 13 %. Stent occlusion occurred in 28 patients (22 %). Overall median stent patency was 477 days; overall median survival was 173 days. Stent occlusion, confirmed by endoscopic retrograde cholangiopancreatography, was successfully treated with plastic stents in all patients. Cost analysis revealed estimated costs of €3440 per patient for palliative treatment with the Diamond stent.

Conclusions: The Diamond stent compares favorably with other biliary metal stents for patients requiring biliary drainage of malignant jaundice.

References

A. Ferlitsch,M.D. 

Department of Internal Medicine IV
Division of Gastroenterology and Hepatology
University of Vienna

Waehringer Guertel 18 - 20
1090 Vienna
Austria


Fax: + 43-1-404004735

Email: arnulf.ferlitsch@akh-wien.ac.at